Episode
Making Disease Optional, Rewriting the Future of Human Health
- Published
- Mar 26, 2026
- Duration seconds
- 1736
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/the-innovation-imperative/2661574
Actions
POST https://stenobird.com/v1/public/podcasts/the-innovation-imperative-business-law-for-startups-and-investors-7759091/episodes/making-disease-optional-rewriting-the-future-of-human-health/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-innovation-imperative-business-law-for-startups-and-investors-7759091/making-disease-optional-rewriting-the-future-of-human-health.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
As artificial intelligence (AI) adoption expands, entrepreneurs face a defining question: How do you use today's technology to solve tomorrow's problems? In this episode of "The Innovation Imperative," Patrick Driscoll is joined by Partner Adam Matherly and Naveen Jain, founder and CEO of Viome, for a conversation on entrepreneurial philosophy, Viome's mission and the role AI has played in the company's growth. A serial entrepreneur with more than five companies to his name, Mr. Jain shares the framework he applies to every venture: Why this? Why now? Why me? Answering those questions, he explains, sharpens a founder's objectives and gives investors a clearer picture of the opportunity. Mr. Jain also discusses what led him to launch Viome and describes the company's work using RNA and microbiome analysis to personalize nutrition based on individual biology. He closes with advice for entrepreneurs on how to tell their story to investors and why building long-term relationships with legal teams who understand your vision matters.